Lupus is one of the most prevalent systemic autoimmune diseases. It is a multifactorial disease in which genetic, epigenetic and environmental factors play significant roles. The pathogenesis of lupus is not yet well understood. However, deregulation of microRNAs (miRNAs) – one of the post-transcriptional regulators of genes – can contribute to the development of autoimmune diseases. Over the last two decades, advances in the profiling of miRNA using microarray have received much attention, and it has been demonstrated that miRNAs play a regulatory role in the pathogenesis of lupus. Therefore, dysregulated miRNAs can be considered as promising diagnostic biomarkers for lupus. This article is an overview of lupus-related miRNA profiling studies and arrays in the Gene Expression Omnibus (GEO) database. The aims of our study were to widen current knowledge of known dysregulated miRNAs as potential biomarkers of SLE and to introduce a bioinformatics approach to using microarray data and finding novel miRNA and gene candidates for further study. We identified hsa-miR-4709-5p, hsa-miR-140, hsa-miR-145, hsa-miR-659, hsa-miR-134, hsa-miR-150, hsa-miR-584, hsa-miR-409 and hsa-miR-152 as potential biomarkers by integrated bioinformatics analysis.
YazdanyJDall’EraM.Definition and classification of lupus and lupus-related disorders. In: WallaceDJHahnBV (eds) Dubois’ lupus erythematosus and related syndromes. 9th ed.
Amsterdam:
Elsevier, 2019, pp.15–22.
2.
YanivGTwigGShorDB-A, et al.
A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients.Autoimmun Rev2015;
14: 75–79.
3.
KurienBScofieldR.Autoantibody determination in the diagnosis of systemic lupus erythematosus.Scand J Immunol2006;
64: 227–235.
4.
SoléCDomingoSFerrerBMolinéTOrdi-RosJCortés-HernándezJ.MicroRNA expression profiling identifies miR-31 and miR-485-3p as regulators in the pathogenesis of discoid cutaneous lupus.J Invest Dermatol2019;
139: 51–61.
5.
MisraRGuptaR.Biomarkers in lupus nephritis.Int J Rheum Dis2015;
18: 219–232.
6.
MokCC.Biomarkers for lupus nephritis: a critical appraisal. J Biomed Biotechnol2010;
2010: 638413.
7.
GualtierottiRBiggioggeroMPenattiAMeroniPL.Updating on the pathogenesis of systemic lupus erythematosus.Autoimmun Rev2010;
10: 3–7.
BallarinoMPaganoFGirardiE, et al.
Coupled RNA processing and transcription of intergenic primary microRNAs.Mol Cell Biol2009;
29: 5632–5638.
14.
HibioNHinoKShimizuENagataYUi-TeiK.Stability of miRNA 5′ terminal and seed regions is correlated with experimentally observed miRNA-mediated silencing efficacy.Sci Rep2012;
2: 996.
15.
BartelDP.MicroRNAs: genomics, biogenesis, mechanism, and function.Cell2004;
116: 281–297.
16.
ReczkoMMaragkakisMAlexiouPGrosseIHatzigeorgiouAG.Functional microRNA targets in protein coding sequences.Bioinformatics2012;
28: 771–776.
SinghRPMassachiIManickavelS, et al.
The role of miRNA in inflammation and autoimmunity.Autoimmun Rev2013;
12: 1160–1165.
19.
PanWZhuSYuanM, et al.
MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1.J Immunol2010;
184: 6773–6781.
20.
YuanYKasarSUnderbayevC, et al.
Role of microRNA-15a in autoantibody production in interferon-augmented murine model of lupus.Mol Immunol2012;
52: 61–70.
21.
HanXWangYZhangX, et al.
MicroRNA-130b ameliorates murine lupus nephritis through targeting the type I interferon pathway on renal mesangial cells.Arthritis Rheumatol2016;
68: 2232–2243.
22.
Cardenas-GonzalezMSrivastavaAPavkovicM, et al.
Identification, confirmation, and replication of novel urinary microRNA biomarkers in lupus nephritis and diabetic nephropathy. Clin Chem2017;
63: 1515–1526.
23.
PritchardCCChengHHTewariM.MicroRNA profiling: approaches and considerations.Nat Rev Genet2012;
13: 358–369.
24.
RaiGRaiRSaeidianAHRaiM.Microarray to deep sequencing: transcriptome and miRNA profiling to elucidate molecular pathways in systemic lupus erythematosus.Immunol Res2016;
64: 14–24.
25.
DaiYHuangY-STangM, et al.
Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients.Lupus2007;
16: 939–946.
26.
TeJLDozmorovIMGuthridgeJM, et al.
Identification of unique microRNA signature associated with lupus nephritis.PLoS One2010;
5: e10344.
27.
DaiRZhangYKhanD, et al.
Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus.PLoS One2010;
5: e14302.
28.
LinLHronJDPengSL.Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a.Immunity2004;
21: 203–213.
29.
OuyangWBeckettOFlavellRALiMO.An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance.Immunity2009;
30: 358–371.
30.
LinLGerthAJPengSL.Active inhibition of plasma cell development in resting B cells by microphthalmia-associated transcription factor.J Exp Med2004;
200: 115–122.
31.
WangHPengWOuyangXLiWDaiY.Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus.Transl Res2012;
160: 198–206.
32.
ZhouHHasniSAPerezP, et al.
miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1.J Am Soc Nephrol2013;
24: 1073–1087.
33.
CarlsenALSchetterAJNielsenCT, et al.
Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum2013;
65: 1324–1334.
34.
Navarro-QuirozEPacheco-LugoLLorenziH, et al.
High-throughput sequencing reveals circulating miRNAs as potential biomarkers of kidney damage in patients with systemic lupus erythematosus.PLoS One2016;
11: e0166202.
35.
KusaoiMYamajiKIshibeY, et al.
Separation of circulating MicroRNAs using apheresis in patients with systemic lupus erythematosus.Ther Apher Dial2016;
20: 348–353.
36.
WangYLiangJQinH, et al.
Elevated expression of miR-142-3p is related to the pro-inflammatory function of monocyte-derived dendritic cells in SLE.Arthritis Res Ther2016;
18: 263.
37.
RudnickiMPercoPD’HaeneB, et al.
Renal micro RNA- and RNA-profiles in progressive chronic kidney disease. Eur J Clin Invest2016;
46: 213–226.
38.
KatsuyamaEYanMWatanabeKS, et al.
Downregulation of miR-200a-3p, targeting CtBP2 complex, is involved in the hypoproduction of IL-2 in systemic lupus erythematosus–derived T cells.J Immunol2017;
198: 4268–4276.
39.
SunLAkiyamaKZhangH, et al.
Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans.Stem Cells2009;
27: 1421–1432.
40.
RenGChenXDongF, et al.
Concise review: mesenchymal stem cells and translational medicine: emerging issues.Stem Cells Transl Med2012;
1: 51–58.
41.
ZhaoSWangYLiangY, et al.
MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum2011;
63: 1376–1386.
42.
LiuSLiuDChenC, et al.
MSC transplantation improves osteopenia via epigenetic regulation of notch signaling in lupus.Cell Metab2015;
22: 606–618.
43.
QinHZhuXLiangJ, et al.
MicroRNA-29b contributes to DNA hypomethylation of CD4+ T cells in systemic lupus erythematosus by indirectly targeting DNA methyltransferase 1.J Dermatol Sci2013;
69: 61–67.
44.
ZhaoX-FPanH-FYuanH, et al.
Increased serum interleukin 17 in patients with systemic lupus erythematosus.Mol Biol Rep2010;
37: 81–85.
45.
RanaAMinzRAggarwalRAnandSPasrichaNSinghS.Gene expression of cytokines (TNF-α, IFN-γ), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus. Lupus2012;
21: 1105–1112.
46.
MaoCSinghAK.IL-lβ gene expression in B cells derived from the murine MRL/lpr model of lupus. Autoimmunity1996;
24: 71–79.
47.
PetriMStohlWChathamW, et al.
Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.Arthritis Rheum2008;
58: 2453–2459.
48.
YooD.Anticytokine therapy in systemic lupus erythematosus.Lupus2010;
19: 1460–1467.
49.
FurieRPetriMZamaniO, et al.
A Phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.Arthritis Rheum2011;
63: 3918–3930.
50.
LuoSYDingSLiaoJY, et al.
Excessive miR-152-3p results in increased BAFF expression in SLE B-cells by inhibiting the KLF5 expression.Front Immunol2019;
10: 1127.
51.
ZhuSPanWSongX, et al.
The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α.Nat Med2012;
18: 1077–1086.
52.
LiuLLiuYYuanMXuLSunH.Elevated expression of microRNA-873 facilitates Th17 differentiation by targeting forkhead box O1 (Foxo1) in the pathogenesis of systemic lupus erythematosus.Biochem Biophys Res Commun2017;
492: 453–460.
53.
Solé-MarcéCCortés-HernándezJFerrerBGimenezMOrdi-RosJ.OP0082 Microarray and miRNA analysis of cutaneous lupus: differential expression in discoid lupus versus subacute lupus. Ann Rheum Dis2015;
74: 99–100.
54.
ZhaoXTangYQuB, et al.
MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum2010;
62: 3425–3435.
55.
DingSLiangYZhaoM, et al.
Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheum2012;
64: 2953–2963.
56.
FanWLiangDTangY, et al.
Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus.Arthritis Rheum2012;
64: 3715–3725.
57.
Perez-HernandezJFornerMJPintoCChavesFJCortesRRedonJ.Increased urinary exosomal microRNAs in patients with systemic lupus erythematosus. PLoS One2015;
10: e0138618.
58.
HaMKimVN.Regulation of microRNA biogenesis.Nat Rev Mol Cell Biol2014;
15: 509–524.
59.
LiuQParooZ.Biochemical principles of small RNA pathways.Annu Rev Biochem2010;
79: 295–319.
60.
LiMXieHXiongW, et al.
[MicroRNA and metabolism regulation].Zhong Nan Da Xue Xue Bao Yi Xue Ban2013;
38: 318–322.
61.
Alemán-ÁvilaICadena-SandovalDMoralesMJRamírez-BelloJ, et al.
[MicroRNA en Enformedades Autoinmunes]. Gac Med Mex2019;
155: 63–71.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
